DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.
-
Upload
elaine-flowers -
Category
Documents
-
view
221 -
download
2
Transcript of DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.
![Page 1: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/1.jpg)
DIAGNOSIS OF HEMOPHILIA
Nairobi, Kenya
June 24, 2013
![Page 2: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/2.jpg)
JIM MUNN, R.N., M.S.
Program Nurse Coordinator
University of Michigan HTC
Ann Arbor, MI, USA
Chair – WFH Nursing Committee
Acknowledgement:
Slides 20,21, 23-28 reproduced with permission from Partners in Bleeding Disorders Education Program www.partnersprn.org
![Page 3: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/3.jpg)
OBJECTIVES
• Discuss the history of hemophilia
• Illustrate the clotting cascade and how bleeding occurs
• Describe the two main types of hemophilia
• Classify the severities of hemophilia
• List common presenting symptoms in patients with hemophilia
• Examine the process of diagnosing hemophilia
• Identify common labs used to diagnose hemophilia
![Page 4: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/4.jpg)
EARLY OBSERVATIONS
“If a woman had her first son circumcised and he died as a result of the circumcision, which enfeebled his strength, and she similarly had her second [son] circumcised and he died as a result of the circumcision - whether [the latter child] was from her first husband or her second husband - the third son may not be circumcised at the proper time [on the eighth day of life]…”2
Twelfth Century Physician and Talmudist Maimonides states in the Mishneh Torah1
1. Rosner F. “Moses Maimonides.” Ann Intern Med. 1965;372:1135-1204.2. Mishneh Torah, Hilkhot Milah. 1:18.
![Page 5: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/5.jpg)
EARLY OBSERVATIONS
1803: John Conrad Otto• Provided first accurate account of
hemophilia in the modern medical literature
• His investigation of “bleeders” was published in a New York journal under the title, “An Account of an Hemorrhagic Disposition Existing in Certain Families”
• Traced to woman who settled in Plymouth, New Hampshire in 1720
Otto JC. The Medical Repository. 1803;Vol VI (No 1):1-4.
![Page 6: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/6.jpg)
EARLY OBSERVATIONS
1820: Nasse of Bonn
• German physician 1778-1851
• Formulated observations on inheritance of hemophilia
• “Nasse’s Law”: Transmitted by unaffected females to their sons
Nasse CF. Arch Med Erfahr. 1(1820):385.
![Page 7: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/7.jpg)
EARLY OBSERVATIONS
1828: The word “hemophilia” first appears in a description of inherited bleeding disorders by Physician Frederick Hopff at the University of Zurich
1840: First recorded case of hemophilia treatment by transfusion written by Samuel Lane in The Lancet 1
1893: First documentation of abnormal prolongation of coagulation in capillary tube in hemophilics2
1. Farr AD. J Royal Soc Med. April 1981;74(4):301-305.2. Wright AE. Br Med J. 1893;2:223-225.
![Page 8: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/8.jpg)
THE ROYAL DISEASE: QUEEN VICTORIA FAMILY TREE
![Page 9: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/9.jpg)
THE COAGULATION SYSTEM
Fibrinolysis Coagulation inhibitors
Procoagulants
Platelet
EndothelialCell
![Page 10: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/10.jpg)
THE CLOTTING CASCADE
Intrinsic pathway (I.P.) Extrinsic pathway (E.P.)
XII
XIIX
X
VII
Prothrombin (II) Thrombin
Fibrinogen Fibrin
CLOT FORMATION
VIII
V
XIII
![Page 11: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/11.jpg)
HOW DOES CLOTTING OCCUR?
![Page 12: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/12.jpg)
WHAT IS HEMOPHILIA?
• Rare, genetic condition
• Gene located on the X chromosome
• Results in bleeding manifestations in affected individuals
• Present at birth and continues throughout life
• Decreased amount or impaired functioning of one of the plasma proteins
• Usually factor VIII (eight) or IX (nine)
• Factor levels usually do not change over time
![Page 13: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/13.jpg)
WHY DO PEOPLE WITH HEMOPHILIA BLEED LONGER?
• In hemophilia, one clotting factor is missing, or the level of that factor is low.
• It is difficult for the blood to form a clot, so bleeding continues longer than usual (not faster).
![Page 14: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/14.jpg)
TYPES OF HEMOPHILIA
Hem A/Factor VIII
Hem B/Factor IX
Hem C/Factor XI
1:5,000 males 80-85%
1:25,000 males 15-20%
Types Prevalence % of Cases
All types:
• Affect all races
• Worldwide distribution
![Page 15: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/15.jpg)
SEVERITY OF HEMOPHILIA
• Low levels of factor VIII (eight) = hemophilia A.
• Low levels of factor IX (nine) = hemophilia B.
• Hemophilia A and B can be mild, moderate, or severe, depending on the level of clotting factor.
Severity of symptoms often corresponds to factor level
![Page 16: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/16.jpg)
COMMON PRESENTING SYMPTOMS IN HEMOPHILIA
• Bleeding at circumcision
• Mouth bleeds in young children
• Excessive bruising, hematomas – especially in areas not subjected to bumps and scrapes
• Head bleeding related to birth trauma
• Joint bleeding
• Muscle bleeding
• Bleeding after surgery, dental work, or trauma
• In severe hemophilia, bleeding can be spontaneous
![Page 17: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/17.jpg)
DIAGNOSING HEMOPHILIA: HISTORY AND PHYSICAL
• Accurate and detailed history with assessment of bleeding episodes and trauma in individuals with bleeding disorders is essential for determining appropriate care
• Use age-appropriate approach
• Get a patient and family history
• Start general (ROS), get specific
• History and assessment may be as, or more, important as labs/imaging
• Listen to the patient and family
• The process is continuous from first notification of event to follow-up
![Page 18: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/18.jpg)
THE 7 HISTORY AND ASSESSMENT QUESTIONS
1. What are the symptoms?
2. How long have the symptoms been present?
3. What treatment was given, and when?
4. Did an injury happen before the symptoms started?
5. Did a similar problem occur in the past?
6. How was that problem treated?
7. Did that treatment resolve the issue?
![Page 19: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/19.jpg)
LABORATORY EVALUATION
• Laboratory evaluation is guided by thorough history & physical examination
• Clinical impression is critical to determine:
- Extent of evaluation
- Phase of coagulation most likely abnormal
- Need for repeated evaluations
![Page 20: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/20.jpg)
LABORATORY EVALUATION: GUIDED BY SYMPTOMS
• Petechiae
• Abnormal bruising
• Mucocutaneous bleeding
Abnormal platelet number or function
• Deep tissue, muscle, joint bleeding
• Abnormal bruising
• Bleeding with injury, surgery
→ Abnormal procoagulants
• Delayed bleeding
→ Abnormal fibrinolysis
![Page 21: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/21.jpg)
THE CLOTTING CASCADE: PT AND APTT
Intrinsic pathway (I.P.) Extrinsic pathway (E.P.)
XII
XIIX
X
VII
Prothrombin (II) Thrombin
Fibrinogen Fibrin
CLOT FORMATION
VIII
V
XIII
APTT PT
![Page 22: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/22.jpg)
LABORATORY EVALUATION: APTT
• Activated partial thromboplastin time (aPTT)
• Non-specific test of “intrinsic system”
• aPTT screens for abnormality in factors VIII, IX, XI, XII
Activated Partial Thromboplastin Time. Virginia Commonwealth University, 2005. http://www.pathology.vcu.edu/clinical/coag/aPTT.pdf.Laboratory Evaluation of Hemostasis. Virginia Commonwealth University, no date. http://www.pathology.vcu.edu/clinical/coag/Lab%20Hemostasis.pdf.
![Page 23: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/23.jpg)
LABORATORY EVALUATION: PT
• Prothrombin time (PT)
• Tests efficiency of “extrinsic system”
• PT sole abnormality factor VII
• Abnormality of PT may be due to deficiency in factors VII, X, V
• Somewhat useful for detecting changes in factors II (prothrombin) and I (fibrinogen)
Laboratory Evaluation of Hemostasis. Virginia Commonwealth University, no date. http://www.pathology.vcu.edu/clinical/coag/Lab%20Hemostasis.pdf
![Page 24: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/24.jpg)
LABORATORY EVALUATION: PROLONGED PT AND APTT
Common pathway
• Both PT & aPTT prolonged
• May be due to deficiency in factors X, V, II, I (fibrinogen)
• May also indicate vitamin K deficiency: factors II, VII, IX, X
Laboratory Evaluation of Hemostasis. Virginia Commonwealth University, no date. http://www.pathology.vcu.edu/clinical/coag/Lab%20Hemostasis.pdf
![Page 25: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/25.jpg)
MIXING STUDY
• Prolonged coagulation screening tests such as PT & aPTT should first be followed by a mixing study
• Mixing study consists of mixing equal parts the patient’s plasma with a known normal plasma
• Coagulation test is then repeated
• Correction of the test to the normal range = Factor deficiency
• Lack of correction of the test to the normal range = Inhibitor
Partial Thromboplastin Time Mixing Study. University of Alabama at Birmingham Coagulation Service, no date. http://peir.path.uab.edu/coag/article_101.shtm
![Page 26: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/26.jpg)
Mixed withnormal plasma
aPTT corrects =
Factor deficiency
Patient with prolonged
aPTT
+
![Page 27: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/27.jpg)
Mixed withnormal plasma
aPTT does not correct or
re-prolongs with incubation =
Inhibitor
Patient with prolonged
aPTT
+
![Page 28: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/28.jpg)
SPECIFIC FACTOR ASSAYS
• Factor VIII level
• Factor IX level
• May need repeat testing as factor IX levels are typically low at birth due to immature liver (vitamin K-dependent protein)
• Cord blood sampling can be done
• Exposure to blood products for treatment can falsely elevate factor levels
![Page 29: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/29.jpg)
SUMMARY
• Hemophilia has been around as long as people have been around.
• Hemophilia is not a “Royal Disease”.
• Symptoms typically appear earlier in life in severe disease.
• Clotting involves a complex series of reactions between a number of components.
• The diagnosis of hemophilia requires a coordinated approach.
• Careful history and physical should precede any laboratory investigations.
• Labs may need to be repeated.
![Page 30: DIAGNOSIS OF HEMOPHILIA Nairobi, Kenya June 24, 2013.](https://reader036.fdocuments.us/reader036/viewer/2022062314/56649de35503460f94ada0f0/html5/thumbnails/30.jpg)
ADDITIONAL WFH RESOURCES
• Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual
• Guidelines for the Management of Hemophilia, 2nd edition, Section 3.
Visit the Publications Library at www.wfh.org/publications for free copies